CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19

Clinical trial NCT04378244 · WITHDRAWN

Trial details

NCT number: NCT04378244
Sponsor: Aveni Foundation
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

COVID-19 Cytokine Storm Acute Respiratory Distress Syndrome

Start date: 2022-12-12
Primary completion: 2023-12-12
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.